4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-068454
Executive VP, Head of R&D gave up 12,607 shares (to pay taxes)
- Executive VP, Head of R&D acquired 26,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Tony W Executive VP, Head of R&D | 2021-12-03 | Option exercise | +26,667 | 64,971 | D: show line 1 in the form | ||
| Ho Tony W Executive VP, Head of R&D | 2021-12-06 | Shares withheld for taxes | −12,607 | $69.17 | $872,026 | 52,364 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ho Tony W Executive VP, Head of R&D | 2021-12-03 | Option exercise · Restricted Stock Units | +26,667 | 13,333 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…